HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pedro V Baptista Selected Research

Carcinoma (Carcinomatosis)

3/2024Copper(II) Complexes with 2,2':6',2″-Terpyridine Derivatives Displaying Dimeric Dichloro-μ-Bridged Crystal Structure: Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models.
11/2022In Vitro and In Vivo Biological Activity of Ruthenium 1,10-Phenanthroline-5,6-dione Arene Complexes.
1/2022Manganese(I) tricarbonyl complexes as potential anticancer agents.
2/2021Cu(I) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action.
10/2020Antiproliferative Activities of Diimine-Based Mixed Ligand Copper(II) Complexes.
11/2019Antiproliferative activity of heterometallic sodium and potassium-dioxidovanadium(V) polymers.
1/2019Ionic Liquids and Salts from Ibuprofen as Promising Innovative Formulations of an Old Drug.
10/2018The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pedro V Baptista Research Topics

Disease

48Neoplasms (Cancer)
04/2024 - 02/2010
10Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 08/2014
8Carcinoma (Carcinomatosis)
03/2024 - 10/2018
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2021 - 02/2010
3Lung Neoplasms (Lung Cancer)
04/2024 - 10/2013
3Breast Neoplasms (Breast Cancer)
02/2023 - 01/2017
3Inflammation (Inflammations)
01/2023 - 05/2015
3Adenocarcinoma
02/2021 - 05/2015
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 10/2018
2Hypoxia (Hypoxemia)
01/2023 - 01/2022
2Hyperthermia
01/2021 - 09/2020
2Leukemia
01/2019 - 01/2017
2Philadelphia Chromosome
11/2018 - 07/2016
2Malaria
08/2015 - 01/2012
1Adenocarcinoma of Lung
04/2024
1Prostatic Neoplasms (Prostate Cancer)
02/2023
1Glioblastoma (Glioblastoma Multiforme)
12/2022
1Brain Neoplasms (Brain Tumor)
12/2022
1Melanoma (Melanoma, Malignant)
11/2022
1Ischemia
01/2022
1Reperfusion Injury
01/2022
1Disease Progression
11/2021
1Alzheimer Disease (Alzheimer's Disease)
03/2021
1Colonic Neoplasms (Colon Cancer)
01/2021
1Necrosis
02/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Circulating Neoplastic Cells
01/2019

Drug/Important Bio-Agent (IBA)

26GoldIBA
07/2021 - 02/2010
9Doxorubicin (Adriamycin)FDA LinkGeneric
03/2024 - 01/2017
7Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2019
4Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2019
4DNA (Deoxyribonucleic Acid)IBA
03/2022 - 09/2015
3MicroRNAs (MicroRNA)IBA
04/2024 - 03/2013
3Tumor Biomarkers (Tumor Markers)IBA
03/2022 - 06/2014
3RNA (Ribonucleic Acid)IBA
03/2013 - 02/2010
2CopperIBA
03/2024 - 09/2015
2SteroidsIBA
02/2023 - 02/2014
2Testosterone (Sustanon)FDA Link
02/2023 - 02/2014
2ErbB Receptors (EGF Receptor)IBA
11/2021 - 10/2017
2Cisplatin (Platino)FDA LinkGeneric
06/2021 - 10/2020
2Peptides (Polypeptides)IBA
03/2021 - 01/2017
2SilverIBA
01/2021 - 10/2019
2Nucleic AcidsIBA
07/2020 - 06/2017
2Cetuximab (Erbitux)FDA Link
11/2019 - 06/2014
2LigandsIBA
10/2018 - 09/2015
2NanoconjugatesIBA
06/2017 - 10/2013
2OligonucleotidesIBA
01/2017 - 08/2014
2Small Interfering RNA (siRNA)IBA
05/2015 - 10/2013
1Indicators and Reagents (Reagents)IBA
04/2024
1Complementary DNA (cDNA)IBA
04/2024
1Bovine Serum AlbuminIBA
03/2024
1Estradiol (Delestrogen)FDA LinkGeneric
02/2023
1Coloring Agents (Dyes)IBA
02/2023
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
02/2023
11,10-phenanthrolineIBA
01/2023
1RutheniumIBA
01/2023
1Cytostatic AgentsIBA
01/2023
1Protons (Proton)IBA
12/2022
1BoronIBA
12/2022
1TriterpenesIBA
11/2022
1AnionsIBA
11/2022
1Liposomes (Liposome)IBA
01/2022
1QuercetinIBA
01/2022
1TriazolesIBA
01/2022
1Coordination ComplexesIBA
01/2022
1AcridinesIBA
01/2022
1Phosphotransferases (Kinase)IBA
11/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021
1Transforming Growth Factor beta (TGF-beta)IBA
11/2021
1NF-kappa B (NF-kB)IBA
11/2021
1beta CateninIBA
11/2021
1Amyloid beta-PeptidesIBA
03/2021
1TrabectedinIBA
01/2021
1OxindolesIBA
01/2021
1MetalsIBA
01/2021
1OxidesIBA
01/2021
1GraphiteIBA
01/2021
1Oxygen (Dioxygen)IBA
10/2020
1HalogensIBA
10/2020
1IronIBA
09/2020
1FormazansIBA
02/2020
1Annexin A5IBA
02/2020
1Antineoplastic Agents (Antineoplastics)IBA
11/2019
1Circulating Tumor DNAIBA
01/2019
1SaltsIBA
01/2019
1Protein Isoforms (Isoforms)IBA
11/2018
1AcetyleneIBA
10/2018
1PropaneIBA
10/2018
1Diacetyl (Biacetyl)IBA
10/2018
1nonaneIBA
10/2018
1tesmilifene (DPPE)IBA
10/2018

Therapy/Procedure

18Therapeutics
01/2023 - 11/2015
8Drug Therapy (Chemotherapy)
01/2023 - 01/2017
4Precision Medicine
02/2023 - 11/2014
3Lasers (Laser)
10/2020 - 11/2017
2Photothermal Therapy
01/2017 - 11/2014
1Radiotherapy
12/2022
1Induced Hyperthermia (Thermotherapy)
10/2020